An Infected Cryopreserved Precision-Cut Lung Slice Model for Drug Susceptibility Testing in Pneumocystis murina Pneumonia

Precision-cut lung slices (PCLS) preserve native three-dimensional lung architecture and cellular complexity, providing a valuable ex vivo platform for studying pulmonary host-pathogen interactions. However, existing PCLS infection models typically introduce microorganisms into previously uninfected tissue, while fresh PCLS prepared from infected lungs have limited experimental flexibility and scalability. To our knowledge, cryopreserved PCLS generated from lungs with an established in vivo pulmonary infection have not been described. Herein, we evaluated cryopreserved PCLS from mice with established Pneumocystis murina pneumonia (PCP) as an ex vivo platform for infection and therapeutic studies. PCLS were prepared from dexamethasone-immunosuppressed mice with established PCP, rested for 24 h, cryopreserved in a novel freezing medium for 12 days in liquid nitrogen, rapidly thawed, recovered for 24 h, and treated with pentamidine for 72 h. Viability was assessed in uninfected and PCP-infected PCLS before and after cryopreservation. Although post-thaw viability decreased in both groups, substantial viability was still retained, allowing further experimentation. qPCR showed that cryopreservation did not alter expression of the type I and type II alveolar epithelial markers podoplanin (Pdpn) and surfactant protein C (Sftpc) in either group. Importantly, pentamidine significantly reduced Pneumocystis mitochondrial small subunit (mtSSU) rRNA levels in thawed PCP-infected PCLS, demonstrating suitability for anti-Pneumocystis drug testing. These findings establish the first cryopreserved ex vivo PCP model using infected mouse PCLS, preserving endogenous fungal burden and infection-associated host responses while enabling flexible, scalable studies of Pneumocystis biology, host-pathogen interactions, therapeutic efficacy, and potentially other pulmonary infections.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.19.767844
Primary Topic
Pneumocystis jirovecii pneumonia detection and treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

An Infected Cryopreserved Precision-Cut Lung Slice Model for Drug Susceptibility Testing in Pneumocystis murina Pneumonia

Theodore J. Kottom, ANDREW HAR LIMPER, Madeline R. Pellegrino, Jenna Lillie McLean
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Pneumocystis jirovecii pneumonia detection and treatment
preprint

An Infected Cryopreserved Precision-Cut Lung Slice Model for Drug Susceptibility Testing in Pneumocystis murina Pneumonia

Theodore J. Kottom, ANDREW HAR LIMPER, Madeline R. Pellegrino, Jenna Lillie McLean
preprint en

Abstract

Precision-cut lung slices (PCLS) preserve native three-dimensional lung architecture and cellular complexity, providing a valuable ex vivo platform for studying pulmonary host-pathogen interactions. However, existing PCLS infection models typically introduce microorganisms into previously uninfected tissue, while fresh PCLS prepared from infected lungs have limited experimental flexibility and scalability. To our knowledge, cryopreserved PCLS generated from lungs with an established in vivo pulmonary infection have not been described. Herein, we evaluated cryopreserved PCLS from mice with established Pneumocystis murina pneumonia (PCP) as an ex vivo platform for infection and therapeutic studies. PCLS were prepared from dexamethasone-immunosuppressed mice with established PCP, rested for 24 h, cryopreserved in a novel freezing medium for 12 days in liquid nitrogen, rapidly thawed, recovered for 24 h, and treated with pentamidine for 72 h. Viability was assessed in uninfected and PCP-infected PCLS before and after cryopreservation. Although post-thaw viability decreased in both groups, substantial viability was still retained, allowing further experimentation. qPCR showed that cryopreservation did not alter expression of the type I and type II alveolar epithelial markers podoplanin (Pdpn) and surfactant protein C (Sftpc) in either group. Importantly, pentamidine significantly reduced Pneumocystis mitochondrial small subunit (mtSSU) rRNA levels in thawed PCP-infected PCLS, demonstrating suitability for anti-Pneumocystis drug testing. These findings establish the first cryopreserved ex vivo PCP model using infected mouse PCLS, preserving endogenous fungal burden and infection-associated host responses while enabling flexible, scalable studies of Pneumocystis biology, host-pathogen interactions, therapeutic efficacy, and potentially other pulmonary infections.

bioRxiv (Cold Spring Harbor Laboratory)
Mayo Clinic (US)
National Institutes of Health
Good health and well-being
Pneumocystis jirovecii pneumonia detection and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon